Recent genome-wide association studies have identified 15 single nucleotide polymorphisms (SNPs) associated with non-Hodgkin lymphoma (NHL) and its subtypes. Because the incidence and subtype portion of NHL between the Chinese population and Caucasian populations are substantially different, we assessed the associations of these SNPs with NHL risk in a case-control study consisting of 792 cases and 1542 controls derived from the Chinese population. Odds ratios (OR) and 95% confidence intervals (CI) were computed by logistic regression. False-positive report probability was also assessed for significant findings. We found that the allele frequencies of the 15 SNPs in our study population significantly differed from those in Caucasian populations, with rs13397985, rs735665 and rs11083846 being extremely rare in Chinese. Only two variants (rs872071 in IRF4 and rs2647012 in HLA class II) were significantly associated with NHL risk in Chinese, with the ORs of 1.20 (95% CI, 1.05-1.38; P = 0.009) and 1.20 (95% CI, 1.03-1.39; P = 0.018) for per allele of rs872071 and rs2647012, respectively, calculated using an additive model. These results indicate a substantial different genetic background for susceptibility to NHL among the different ethnic populations.
Introduction
Non-Hodgkin lymphoma (NHL), a heterogeneous group of neoplasm derived from T cells or B cells, is the most common hematologic malignancy in the world and the incidence has been increasing significantly in China (1) (2) (3) (4) . B-cell lymphomas (BCLs) mainly consist of diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), marginal zone lymphoma (MZL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), whereas T-cell lymphomas (TCLs) mainly consist of peripheral TCL, anaplastic large cell lymphoma, T-lymphoblastic lymphoma/leukemia, mycosis fungoides and Sézary syndrome. The different subtypes of NHL are abnormal differentiation and proliferation of the precursor lymphocytes in different developmental stages. Although the etiology of NHL is largely unknown, some infection agents such as human immunodeficiency virus, human T-cell leukemia/lymphoma virus type 1, Epstein-Barr virus and Helicobacter pylori are believed to be involved in the pathogenesis of certain types of NHL (5) (6) (7) (8) . In addition, immune deficiencies and some environmental carcinogens are also etiological factors of NHL (9, 10) . On the other hand, evidence has been accumulated to show that genetic polymorphisms may also play important roles in the development of NHL (11) (12) (13) (14) (15) .
The incidence rate of NHL in Eastern Asia is much lower than that in Europe and North America (1, 4) , and the incidence and distribution of the NHL subtypes across geographic regions are markedly different (2) . Compared with the European and American countries, the incidence rates of FL and CLL/SLL are significantly lower (3) , and peripheral TCL and natural killer/T cell lymphoma are relatively more common in Asia (16) . The difference in the distribution of NHL subtypes is likely to be closely associated with environmental factors and genetic background, but which is the major cause has not been clarified.
Recently, several genome-wide association studies (GWAS) on NHL have been published, reporting the identification of 15 common SNPs influencing risk of NHL and its subtypes. Firstly, six SNPs at 2q13 (rs17483466), 2q37.1 (rs13397985), 6p25.3 (rs872071), 11q24.1 (rs735665), 15q23 (rs7176508) and 19q13. 32 (rs11083846) have been shown to be associated with risk of developing CLL in the UK population (17) . Then another four SNPs at 2q37.3 (rs757978), 8q24.21 (rs2456449), 15q21.3 (rs7169431) and 16q24.1 (rs305061) have been reported to be associated with CLL risk in UK and Spanish populations (18) . In populations of the USA, SNPs rs6457327 at 6p21.33 and rs10484561 at 6p21.32 were associated with risk of FL or DLBCL, whereas rs2647012 showed negative association with FL risk but positive association with MZL risk in the validation stage (19) (20) (21) . In the Japanese population, SNPs rs751837 at 14q32 and rs7097 at 13q12 were associated with risk of DLBCL (22) .
Among above-mentioned SNPs, a few have been independently replicated in populations of European ancestry (23) (24) (25) (26) . However, little or nothing has been known about these loci in risk of the development of NHL in the Chinese population, although a small replication study on CLL in Hong Kong Chinese has been published (27) . In the present study, we performed a relatively larger study in a Han Chinese population in mainland China to evaluate the associations of the 15 SNPs identified by the previous GWAS with risk of NHL including TCL and DLBCL.
Materials and methods

Study subjects and clinical characteristics
This study consisted of 792 patients with NHL and 1542 cancer-free controls. All subjects were unrelated Han Chinese. Of the patients, 727 were consecutively recruited between January 1992 and December 2010 at Cancer Hospital, Chinese Academy of Medical Sciences in Beijing and 65 were recruited at Southwest Hospital, The Third Military Medical University in Chongqing between April and December 2010. The subtypes of NHL were determined according to the WHO classification and the distributions are shown in Table I . Controls were cancer-free individuals selected from a community nutritional survey in Beijing consisting of 2800 individuals based on a physical examination. They were frequency matched to patients on gender. At recruitment, informed consent was obtained from each subject and each participant was interviewed to collect demographic information. The selected characteristics of NHL patients were obtained from clinical records. This study was approved by the Institutional Review Board of the Chinese Academy of Medical Sciences Cancer Institute and Hospital.
SNP selection and genotyping analysis
We selected 15 SNPs at 14 chromosomal regions that have been reported previously to be associated with certain subtypes of NHL by GWAS (17) (18) (19) (20) (21) (22) . Genomic DNA samples from cases and controls were isolated from peripheral blood lymphocytes. Genotypes of these 15 SNPs were determined by polymerase chain reaction-based restriction fragment length polymorphism methods. The PCR primers and restriction enzymes used for genotyping are shown in Supplementary Table I , available at Carcinogenesis Online. The
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genotypes identified by polymerase chain reaction-based restriction fragment length polymorphism methods were further confirmed by direct DNA sequencing of the PCR products. For quality controls, genotyping assays were performed without knowledge of patients' or control status; a 10% masked, random samples of DNA from patients and controls were tested twice by different persons and the results were concordant for all masked duplicated sets.
Statistical analysis
The NHL risk associated with genotype was estimated as odds ratios (ORs) and 95% confidence intervals (95% CIs) computed using logistic regression model adjusted for age and gender. We tested three different genetic models, i.e. dominant, recessive and additive genetic models. For a SNP, the model that had the highest likelihood was considered to be the best-fitting genetic model. Finally, the false-positive report probability (FPRP) was used to evaluate the noteworthiness of the significant associations according to the study of Wacholder et al. (28) . We set a prior probability of 0.01 to detect an OR of 1.5 (or 0.67 for protective effect) for an association with genotypes. We imposed an FPRP cutoff value of 0.5, based on the guidelines by Wacholder and colleagues for rare tumors.
Results
The median age in patients with NHL was 48 (10-84) years compared with 58 (14-85) years in controls. The gender distributions in patients (62.2% of male) and controls (64.6% of male) were similar (Table  I) . These suggest that the matching of cases and controls on gender was adequate. Of 792 NHL cases, 227 (28.7%) were TCL and 565 (71.3%) were BCL. The most common subtype of BCL was DLBCL (n = 376), followed by FL (n = 62), MZL (n = 56), CLL/SLL (n = 30) and mantle cell lymphoma (n = 17).
Among the 15 SNPs investigated, rs13397985, rs735665 and rs11083846 had extremely low minor allele frequencies (MAF) in our study population (all MAF < 0.01 in controls) and these SNPs were excluded in further analysis. Genotype frequencies of the other 12 SNPs in cases and controls are shown in Table II and Supplementary Table II , available at Carcinogenesis Online. The observed genotype frequencies of all these SNPs in controls confirmed to the Hardy-Weinberg equilibrium (all P > 0.05). Multivariate logistic regression analyses showed that there were two SNPs (rs872071 and rs2647012) significantly associated with NHL risk. For rs872071, the variant AG genotype was associated with 30% increased NHL risk compared with the AA genotype (OR = 1.30, 95% CI, 1.08-1.56; P = 0.005); the GG genotype was also associated with increased risk (OR = 1.29, 95% CI, 0.92-1.81) but did not reach statistical significance (P = 0.145). Dominant model showed an OR of 1.30 (95% CI, 1.08-1.54; P = 0.004) for the rs872071 G allele compared with the A allele. For rs2647012, the GA genotype (OR = 1.28, 95% CI, 1.07-1.54; P = 0.007) but not the AA genotype (OR = 1.16, 95% CI, 0.76-1.78; P = 0.484) had an increased risk of NHL compared with the GG genotype. Dominant model showed an OR of 1.27 (95% CI, 1.07-1.52; P = 0.008) for the rs2647012 A allele compared with the G allele (Table II) . The calculation of FPRP showed that associations of the two SNPs (rs872071 and rs2647012) with NHL risk remained noteworthy (FPRP ≤ 0.5) when a prior probability of association of 0.01 or greater was considered. No significant associations were observed between NHL risk and the other 10 SNPs (rs17483466, rs7176508, rs757978, rs2456449, rs7169431, rs305061, rs6457327, rs10484561, rs751837 and rs7097) ( Supplementary Table II , available at Carcinogenesis Online).
Because NHL is a group of several entities with great clinical, histological and biological heterogeneity, we thus examined the association with stratification by TCL or DLBCL and other subtypes. Among the 12 SNPs, 3 were associated with either TCL or DLBCL (Table III) . rs872071, which was associated with CLL in the previous GWAS, was also associated with risk of TCLs; individuals with at least one G allele had OR of 1.38 for TCL (95% CI, 1.02-1.86; P = 0.036) compared with those with two A alleles. rs2647012, which was associated with FL in the previous GWAS, was associated with risk of DLBCL but not TCL, with the OR for at least one A allele being 1.28 (95% CI, 1.02-1.61; P = 0.034) compared with two G alleles. Interestingly, with stratification analysis, we found that rs17483466, which was associated with FL in the previous GWAS, seemed to be also associated with risk of TCL in our study subjects, with the OR being 2.05 (95% CI, 1.02-4.11; P = 0.043) in dominant genetic model.
Discussion
Recent GWAS on NHL have identified many genetic susceptibility loci; however, most initial scan and replication studies were conducted in the populations of European ancestry. Because there exist considerable differences in the prevalence and subtype distribution of NHL among different ethnic populations (1) (2) (3) (4) , it is greatly important to explore the effects of these variations in populations of non-European ancestry. In the present study, we evaluated the 15 reported risk SNPs for NHL in a relatively large case-control study in the Chinese population. We found that there are great differences in the allele frequencies of these SNPs between the Chinese population and populations of European ancestry. Among the 15 common SNPs in populations of European ancestry, 4 (rs17483466, rs757978, rs10484561 and rs751837) had MAF < 0.05 and 3 (rs13397985, rs735665 and rs11083846) had MAF < 0.01 in our study population. We confirmed only two SNPs (rs872071 and rs2647012) associated with either TCL and/or DLBCL in a Chinese population. Recently, a replication study in Hong Kong Chinese showed that among the six significant SNPs reported in the previous GWAS on CLL, only rs872071 is decisively associated with CLL. The associations of the other two SNPs, rs13397985 at SP140 and rs17483466 at ACOXL, are not conclusive because there were only a few samples in the analysis due to very low MAF of these SNPs (27) . These results are consistent with those in the present study. Great differences in the allele frequencies of genetic susceptibility loci between the Chinese population and populations of European ancestry might contribute, at least in part, to the differences in the prevalence and subtype distribution of NHL among these populations. rs872071 was initially identified as a susceptibility loci for CLL by GWAS (17) , and later this SNP was also found to be associated with susceptibility to Hodgkin lymphoma (29) . In the present study, we have extended the association of rs872071 variants to risk of both TCL and BCL in our study population. This SNP is located within the 3′ untranslated region of IRF4 and the G allele is predicted to loss a binding site for myeloid zinc finger 1 compared with the A allele and therefore affects IRF4 mRNA transcription (17, 26) . Interferon regulatory factor 4 (IRF4), a member of the interferon regulatory factor family, plays critical roles in the development of both T cells and B cells (30) (31) (32) . Therefore, it is plausible that this genetic variation is associated with both TCL and BCL. Interestingly, another SNP (rs12203592) in IRF4 has been associated with skin color, eye color and skin tanning response to sunlight by a GWAS (33) . The associations of IRF4 polymorphisms with risk of NHL as well as sunlight sensitivity may imply some interactions between IRF4 variants and sun exposure in the development of NHL.
Previous GWAS in populations of European ancestry have identified three SNPs in chromosomes 6p21.32 (rs10484561 and rs2647012) and 6p21.33 (rs6457327) associated with risk of FL (19) (20) (21) . In this study, we found null associations between rs10484561 and rs6457327 and NHL risk. Moreover, rs2647012, which was shown to be associated with decreased risk of FL in the previous GWAS, was associated with increased risk of DLBCL subtypes in our study population. This SNP is located in the human leukocyte antigen region and this region is highly polymorphic and displays different linkage disequilibrium patterns in different populations, which may attribute to its different effects in different populations. Functional study has suggested that SNPs linked to rs2647012 showed a cis-regulatory mechanism involving modulation of HLA-DQB1 expression, and rs4947344 and rs9275292 may be the causal variants (34) . However, in the Chinese population, rs2647012 is not in high linkage disequilibrium with rs4947344 and rs9275292 (r 2 = 0.22 with rs4947344 and r 2 = 0.30 with rs9275292 in the HapMap CHB data). The study also revealed that there are several enhancer and silencer activity sites in the region of rs2647012 and rs10484561, overlapped by their linked variants. Because of different linkage disequilibrium patterns, it would not be surprising that rs2647012 might affect in different directions the association with different NHL subtypes in different populations of ancestry. Alternatively, the association in different directions of rs2647012 in different NHL subtypes in different populations might also reflect differences in the exposure to environmental etiological factors.
We did not verify the associations between risk of DLBCL and rs751837 and rs7097 (data not shown), two SNPs reported as susceptibility loci for DLBCL in the previous GWAS in the Japanese population (22) , although the allele and genotype frequencies are similar in the control populations of our study and Japanese studies. The reason for this discrepancy is not clear but might be attributable to other undiscovered genetic factors or the differences in environmental etiological factors. Alternatively, the association observed in the Japanese population may be unique to this study population and may not be replicated in other populations. Our study has several strengths. First, we systematically evaluated all the 15 SNPs identified in the previous GWAS and assessed the association in all NHL including TCL and BCL. Secondly, the sample size of our case-control panel is relatively large and derived from a Han Chinese population, which would exclude the biased results due to population stratification. Despite these strengths, we also acknowledge limitations of this study. Due to the lower MAF of some SNPs and rarity of certain subtypes of BCL such as CLL/SLL and FL, the statistical power for some rare SNPs and some NHL subtypes was limited and therefore caution should be taken in interpreting the results. As our cases were sporadic, the locus 6p21.3 identified from GWAS of familial CLL was not involved in our study (35) .
In conclusion, this study showed that two loci (rs872071 at 6p25.3 and rs2647012 at 6p21.32) among the 15 loci reported in the previous GWAS were associated with susceptibility to NHL in a Chinese population. We observed considerably lower allelic and genotype frequencies for some loci in our study population compared with populations of European ancestry, indicating significant differences in genetic background for susceptibility to NHL between different ethnical populations. Further studies in other ethnic populations are warranted to replicate these associations in all subtypes of NHL.
